Skoči na glavni sadržaj

Pregledni rad

https://doi.org/10.2478/acph-2019-0013

Chemistry and pharmacological diversity of quinoxaline motifs as anticancer agents

OLAYINKA O. AJANI orcid id orcid.org/0000-0002-3422-3478 ; Department of Chemistry, Covenant University, CST, Canaanland, P.M.B. 1023, Ota, Ogun State, Nigeria
MARTINS T. NLEBEMUO ; Department of Chemistry, Covenant University, CST, Canaanland, P.M.B. 1023, Ota, Ogun State, Nigeria
JOSEPH A. ADEKOYA ; Department of Chemistry, Covenant University, CST, Canaanland, P.M.B. 1023, Ota, Ogun State, Nigeria
KEHINDE O. OGUNNIRAN ; Department of Chemistry, Covenant University, CST, Canaanland, P.M.B. 1023, Ota, Ogun State, Nigeria
TOLUTOPE O. SIYANBOLA ; Department of Chemistry, Covenant University, CST, Canaanland, P.M.B. 1023, Ota, Ogun State, Nigeria
CHRISTIANA O. AJANAKU ; Department of Chemistry, Covenant University, CST, Canaanland, P.M.B. 1023, Ota, Ogun State, Nigeria


Puni tekst: engleski pdf 1.142 Kb

str. 177-196

preuzimanja: 634

citiraj


Sažetak

Surpassing heart diseases, cancer is taking the lead as the deadliest disease because of its fast rate of spreading in all parts of the world. Tireless commitment to searching for novel therapeutic medicines is a worthwhile adventure in synthetic chemistry because of the drug resistance predicament and regular outbreak of new diseases due to abnormal cell growth and proliferation. Medicinal chemistry researchers and pharmacists have unveiled quinoxaline templates as precursors of importance and valuable intermediates in drug discovery because they have been established to possess diverse pharmacological potentials. Hence, this review highlights the current versatile routes to accessing functionalized quinoxaline motifs and harnessing their documented therapeutic potentials for anticancer drug development.

Ključne riječi

quinoxaline; anticancer activity; pharmacophore

Hrčak ID:

217779

URI

https://hrcak.srce.hr/217779

Datum izdavanja:

30.6.2019.

Posjeta: 1.441 *